IRIS
UGONE, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 499
EU - Europa 193
AS - Asia 145
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 841
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 498
UA - Ucraina 100
CN - Cina 85
DE - Germania 33
SG - Singapore 33
IT - Italia 25
SE - Svezia 18
KR - Corea 13
TR - Turchia 13
FI - Finlandia 8
GB - Regno Unito 5
PL - Polonia 2
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
EU - Europa 1
JM - Giamaica 1
NG - Nigeria 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 841
Salva come PNG Salva come JPEG
Città #
Chandler 170
Jacksonville 58
Princeton 44
Dearborn 30
Singapore 25
Nanjing 17
Wilmington 17
Mountain View 14
Izmir 13
Seoul 13
Jiaxing 8
Nanchang 8
Tianjin 8
Changsha 7
Shenyang 6
Beijing 5
Quartucciu 5
Santa Clara 5
Hebei 4
San Francisco 4
Sassari 4
Ashburn 3
Boardman 3
Cagliari 3
Kunming 3
Norwalk 3
Quartu Sant'elena 3
Taizhou 3
Zhengzhou 3
Ann Arbor 2
Dallas 2
Frankfurt am Main 2
Guangzhou 2
Hangzhou 2
Helsinki 2
Jinan 2
Parma 2
Taiyuan 2
Abuja 1
Berlin 1
Bratislava 1
Brno 1
Canberra 1
Clearwater 1
Hefei 1
Lanzhou 1
London 1
Ningbo 1
Patos de Minas 1
Redwood City 1
Riyadh 1
Seattle 1
Tappahannock 1
Warsaw 1
Washington 1
Xuzhou 1
Totale 525
Salva come PNG Salva come JPEG
Nome #
Nonoxido VIV complexes: Prediction of the EPR spectrum and electronic structure of simple coordination compounds and amavadin 56
Speciation of potential anti-diabetic vanadium complexes in real serum samples 55
Chemistry of oxidomolybdenum(IV) and -(VI) complexes with ONS donor ligands: Synthesis, computational evaluation and oxo-transfer reactions 55
Interaction of Vanadium(IV) Species with Ubiquitin: A Combined Instrumental and Computational Approach 49
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug 49
Speciation in aqueous solution and interaction with low and high molecular mass blood bioligands of [VIVO(oda)(H2O)2], a V compound with in vitro anticancer activity 49
Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations 47
Complex formation between [(η6-p-cym)Ru(H2O)3]2+ and oligopeptides containing three histidyl moieties 45
Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride 42
Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug–myoglobin application 42
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 3. Antioxidant properties and radical production capability 41
Covalent and non-covalent binding in vanadium–protein adducts 39
Decoding Surface Interaction of VIVO Metallodrug Candidates with Lysozyme 38
Synthesis, crystal structures, EPR and DFT studies of first row transition metal complexes of lignin model compound ethylvanillin 36
VIVO complexes with antibacterial quinolone ligands and their interaction with serum proteins 31
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 30
Effect of secondary interactions, steric hindrance and electric charge on the interaction of VIVO species with proteins 30
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 28
VIVO and VIVSpecies Formed in Aqueous Solution by the Tridentate Glutaroimide–Dioxime Ligand – An Instrumental and Computational Characterization 27
Influence of temperature on the equilibria of oxidovanadium(IV) complexes in solution 25
Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations 24
Interaction of the potent antitumoral compounds Casiopeinas® with blood serum and cellular bioligands 22
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes 17
Interaction of pharmacologically active pyrone and pyridinone vanadium(IV,V) complexes with cytochrome c 10
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes 5
Totale 892
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.256
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020115 0 0 6 0 15 22 40 1 15 1 15 0
2020/2021123 15 0 15 0 16 4 22 9 22 20 0 0
2021/2022117 10 0 0 0 9 0 1 11 9 19 9 49
2022/2023286 25 38 5 41 26 37 0 38 52 6 12 6
2023/202481 8 12 3 3 21 2 0 1 1 0 17 13
2024/202538 5 6 27 0 0 0 0 0 0 0 0 0
Totale 892